After long road to approval, Teva and Alvotech believe their Humira biosimilar Simlandi may have an edge
After long road to approval, Teva and Alvotech believe their Humira biosimilar Simlandi may have an edge fkansteiner Fri, 02/23/2024 - 15:19
After long road to approval, Teva and Alvotech believe their Humira biosimilar Simlandi may have an edge fkansteiner Fri, 02/23/2024 - 15:19
Travere's Filspari, J&J's Carvykti win support from CHMP in blitz of positive recommendations kdunleavy Fri, 02/23/2024 - 11:18
Oncopeptides' Pepaxto reaches end of the line in US after FDA yanks approval fkansteiner Fri, 02/23/2024 - 11:13
Venatorx, Melinta's BARDA-funded antibiotic combo falls short with manufacturing-related rejection zbecker Fri, 02/23/2024 - 11:01
To BioMarin CEO Alexander Hardy, hemophilia A gene therapy Roctavian needs 3 stars to align aliu Fri, 02/23/2024 - 09:36
Congressional lawmakers strike back at Biden admin's 'march-in' proposal to corral drug costs fkansteiner Fri, 02/23/2024 - 09:33
'The Top Line': Breaking down Eli Lilly’s ESG formula aellison Fri, 02/23/2024 - 08:48
Sanofi, Regeneron get a step closer on Dupixent COPD nod with FDA priority review kdunleavy Thu, 02/22/2024 - 23:34